Free Trial

Avista Public Acquisition Corp. II (AHPAW) Financials

$0.39 +0.02 (+6.12%)
As of 10/2/2026
Annual Income Statements for Avista Public Acquisition Corp. II

Annual Income Statements for Avista Public Acquisition Corp. II

This table shows Avista Public Acquisition Corp. II's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2021 2022 2023 2024 2025
Period end date 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders
-27 -22 -51 -62 -65
Consolidated Net Income / (Loss)
-27 -22 -51 -62 -65
Net Income / (Loss) Continuing Operations
-27 -22 -51 -62 -65
Total Pre-Tax Income
-34 -26 -64 -71 -66
Total Operating Income
-36 -27 -69 -75 -69
Total Gross Profit
35 59 34 26 18
Total Revenue
35 59 34 26 19
Operating Revenue
35 59 34 26 19
Total Cost of Revenue
0.00 0.00 0.00 0.00 0.30
Operating Cost of Revenue
- - - 0.00 0.30
Total Operating Expenses
70 86 104 101 87
Selling, General & Admin Expense
17 25 33 31 29
Research & Development Expense
39 48 57 55 48
Amortization Expense
13 13 14 17 13
Other Operating Expenses / (Income)
1.21 -0.59 0.19 -2.37 -2.55
Total Other Income / (Expense), net
1.26 0.59 5.06 3.09 2.68
Interest & Investment Income
0.00 0.59 5.06 3.11 2.66
Other Income / (Expense), net
1.27 0.00 0.00 -0.02 0.02
Income Tax Expense
-7.31 -3.73 -14 -9.38 -1.52
Basic Earnings per Share
($0.33) ($0.26) ($0.51) ($0.61) ($0.57)
Weighted Average Basic Shares Outstanding
82.61M 85.32M 99.68M 102.37M 113.64M
Diluted Earnings per Share
($0.33) ($0.26) ($0.51) ($0.61) ($0.57)
Weighted Average Diluted Shares Outstanding
82.61M 85.32M 99.68M 102.37M 113.64M
Weighted Average Basic & Diluted Shares Outstanding
- 115.58M 117.13M 122.13M 144.78M

Quarterly Income Statements for Avista Public Acquisition Corp. II

This table shows Avista Public Acquisition Corp. II's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
Net Income / (Loss) Attributable to Common Shareholders
-14 -19 -14 -16 -13 -18 -16 -17 -14 -7.71 -5.86
Consolidated Net Income / (Loss)
-14 -19 -14 -16 -13 -18 -16 -17 -14 -7.71 -5.86
Net Income / (Loss) Continuing Operations
-14 -19 -14 -16 -13 -18 -16 -17 -14 -7.71 -5.86
Total Pre-Tax Income
-20 -22 -16 -19 -15 -18 -16 -18 -15 -7.27 -6.21
Total Operating Income
-21 -23 -16 -20 -16 -19 -16 -18 -16 -7.83 -6.64
Total Gross Profit
4.82 3.80 7.61 4.17 11 4.15 3.64 2.21 8.36 14 13
Total Revenue
4.82 3.80 7.61 4.17 11 4.15 3.90 2.24 8.38 14 13
Operating Revenue
4.82 3.80 7.61 4.17 11 4.15 3.90 2.24 8.38 14 13
Total Cost of Revenue
- 0.00 0.00 0.00 - 0.00 0.26 0.03 0.01 0.02 0.61
Operating Cost of Revenue
- - 0.00 0.00 - 0.00 0.26 0.03 - 0.02 0.61
Total Operating Expenses
26 26 24 24 27 23 20 20 24 22 19
Selling, General & Admin Expense
7.87 8.34 7.97 7.08 7.36 7.92 7.68 6.78 6.84 6.62 6.65
Research & Development Expense
15 15 14 13 13 13 11 10 14 9.64 9.59
Amortization Expense
3.41 3.41 4.54 3.39 6.06 3.23 3.23 3.23 3.23 6.03 3.05
Other Operating Expenses / (Income)
-0.01 0.05 -2.52 0.15 -0.04 -0.75 -1.92 -0.03 0.15 -0.05 0.15
Total Other Income / (Expense), net
1.18 0.98 0.78 0.68 0.66 0.54 0.46 0.45 1.22 0.56 0.43
Interest & Investment Income
1.18 0.98 0.79 0.69 0.66 0.54 0.44 0.46 1.23 0.49 0.43
Other Income / (Expense), net
- 0.00 -0.01 -0.01 - 0.00 0.03 -0.01 -0.01 0.08 -0.01
Income Tax Expense
-5.98 -2.62 -1.90 -2.71 -2.16 -0.11 0.12 -1.16 -0.37 0.44 -0.35
Basic Earnings per Share
($0.14) ($0.19) ($0.13) ($0.16) ($0.13) ($0.17) ($0.15) ($0.14) ($0.11) ($0.06) ($0.05)
Weighted Average Basic Shares Outstanding
99.68M 100.76M 101.46M 102.39M 102.37M 105.62M 106.15M 114.73M 113.64M 128.25M 128.80M
Diluted Earnings per Share
($0.14) ($0.19) ($0.13) ($0.16) ($0.13) ($0.17) ($0.15) ($0.14) ($0.11) ($0.06) ($0.05)
Weighted Average Diluted Shares Outstanding
99.68M 100.76M 101.46M 102.39M 102.37M 105.62M 106.15M 114.73M 113.64M 128.25M 128.80M
Weighted Average Basic & Diluted Shares Outstanding
117.13M 117.62M 118.16M 121.01M 122.13M 122.34M 122.70M 143.96M 144.78M 144.97M 145.39M

Annual Cash Flow Statements for Avista Public Acquisition Corp. II

This table details how cash moves in and out of Avista Public Acquisition Corp. II's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2021 2022 2023 2024 2025
Period end date 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents
0.00 34 -17 11 -2.07
Net Cash From Operating Activities
-5.67 -3.59 2.35 -40 -36
Net Cash From Continuing Operating Activities
-5.67 -3.59 2.35 -40 -36
Net Income / (Loss) Continuing Operations
-27 -22 -51 -62 -65
Consolidated Net Income / (Loss)
-27 -22 -51 -62 -65
Depreciation Expense
16 18 19 24 22
Amortization Expense
- -0.17 -3.44 -1.50 -0.86
Non-Cash Adjustments To Reconcile Net Income
14 19 25 22 14
Changes in Operating Assets and Liabilities, net
-8.75 -18 12 -22 -6.16
Net Cash From Investing Activities
-4.03 -73 -18 38 6.47
Net Cash From Continuing Investing Activities
-4.03 -73 -18 38 6.47
Purchase of Property, Plant & Equipment
-4.07 -17 -1.64 -1.88 -0.57
Purchase of Investments
0.00 -55 -113 -40 -47
Divestitures
- - - 0.00 3.00
Sale and/or Maturity of Investments
1.27 0.07 100 80 51
Other Investing Activities, net
-1.22 -1.44 -4.44 -0.40 0.00
Net Cash From Financing Activities
9.70 111 -0.89 13 28
Net Cash From Continuing Financing Activities
9.70 111 -0.89 13 28
Issuance of Common Equity
0.00 97 1.21 15 29
Other Financing Activities, net
9.70 14 -2.10 -1.61 -0.77

Quarterly Cash Flow Statements for Avista Public Acquisition Corp. II

This table details how cash moves in and out of Avista Public Acquisition Corp. II's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
Net Change in Cash & Equivalents
-4.89 2.70 1.73 6.44 0.36 -17 7.39 10 -3.01 3.52 -4.71
Net Cash From Operating Activities
-9.12 -17 -12 -6.58 -3.87 -16 -5.15 -9.76 -5.67 -4.91 2.68
Net Cash From Continuing Operating Activities
-9.12 -17 -12 -6.58 -3.87 -16 -5.15 -9.76 -5.67 -4.91 2.68
Net Income / (Loss) Continuing Operations
-14 -19 -14 -16 -13 -18 -16 -17 -14 -7.71 -5.86
Consolidated Net Income / (Loss)
-14 -19 -14 -16 -13 -18 -16 -17 -14 -7.71 -5.86
Depreciation Expense
4.93 4.95 6.10 4.93 7.61 0.97 4.65 4.66 7.71 0.61 0.58
Amortization Expense
-0.79 -0.62 -0.38 -0.29 -0.21 3.54 -0.20 -0.17 -0.24 6.41 3.50
Non-Cash Adjustments To Reconcile Net Income
5.94 5.68 5.93 5.30 5.14 4.17 1.21 4.00 4.21 3.40 3.17
Changes in Operating Assets and Liabilities, net
-5.15 -8.08 -10 -0.14 -3.33 -6.34 5.07 -1.72 -3.17 -7.62 1.30
Net Cash From Investing Activities
4.73 20 13 4.45 0.39 -0.88 12 -7.67 2.71 8.44 -7.62
Net Cash From Continuing Investing Activities
4.73 20 13 4.45 0.39 -0.88 12 -7.67 2.71 8.44 -7.62
Purchase of Property, Plant & Equipment
-0.11 -0.93 -0.75 -0.15 -0.05 -0.21 -0.17 -0.18 -0.01 -0.17 -0.11
Purchase of Investments
-26 -5.42 -11 -8.98 -15 -10 -8.34 -20 -8.28 -9.40 -24
Sale and/or Maturity of Investments
31 27 25 14 15 9.59 18 13 11 18 16
Net Cash From Financing Activities
-0.50 -0.20 0.80 8.57 3.85 0.04 0.24 28 -0.05 0.00 0.23
Net Cash From Continuing Financing Activities
-0.50 -0.20 0.80 8.57 3.85 0.04 0.24 28 -0.05 0.00 0.23
Issuance of Common Equity
0.22 1.00 1.14 8.59 3.90 0.04 0.30 28 0.15 0.00 0.35

Annual Balance Sheets for Avista Public Acquisition Corp. II

This table presents Avista Public Acquisition Corp. II's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2021 2022 2023 2024 2025
Period end date 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets
304 421 375 326 301
Total Current Assets
23 125 95 68 65
Cash & Equivalents
0.00 33 16 28 26
Short-Term Investments
0.00 55 71 32 29
Accounts Receivable
21 30 3.84 5.27 7.39
Prepaid Expenses
1.41 6.40 4.07 3.43 3.93
Plant, Property, & Equipment, net
6.80 20 18 15 9.43
Total Noncurrent Assets
275 276 262 242 226
Goodwill
84 84 84 84 84
Intangible Assets
176 167 155 138 125
Other Noncurrent Operating Assets
15 25 23 20 17
Total Liabilities & Shareholders' Equity
304 421 375 326 301
Total Liabilities
70 80 61 38 34
Total Current Liabilities
21 26 23 15 16
Short-Term Debt
2.54 4.02 1.30 0.53 1.04
Accounts Payable
2.92 2.97 4.41 2.30 1.88
Accrued Expenses
3.75 5.56 7.07 6.14 6.29
Current Deferred Revenue
11 8.21 6.85 2.34 3.16
Other Current Liabilities
0.58 1.78 3.49 3.78 3.88
Total Noncurrent Liabilities
50 54 38 23 18
Capital Lease Obligations
13 24 22 19 16
Noncurrent Deferred Revenue
9.23 4.33 0.86 0.12 0.00
Noncurrent Deferred & Payable Income Tax Liabilities
22 21 11 2.31 0.79
Other Noncurrent Operating Liabilities
5.12 4.14 3.23 1.04 0.39
Total Equity & Noncontrolling Interests
234 341 315 288 267
Total Preferred & Common Equity
234 341 315 288 267
Preferred Stock
0.00 0.00 0.00 0.00 0.00
Total Common Equity
234 341 315 288 267
Common Stock
0.00 330 354 389 433
Retained Earnings
0.00 11 -39 -101 -166
Accumulated Other Comprehensive Income / (Loss)
0.00 0.01 0.05 0.03 0.01

Quarterly Balance Sheets for Avista Public Acquisition Corp. II

This table presents Avista Public Acquisition Corp. II's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026
Period end date 3/31/2023 6/30/2023 9/30/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026 6/30/2026
Total Assets
413 405 392 353 337 332 306 296 310 294 290
Total Current Assets
121 116 107 77 67 67 54 48 66 65 66
Cash & Equivalents
23 21 21 19 21 27 11 18 29 29 24
Short-Term Investments
91 82 75 50 36 32 33 23 31 20 28
Accounts Receivable
1.82 8.61 6.14 4.05 6.88 3.50 6.48 2.71 3.10 13 10
Prepaid Expenses
5.66 4.18 4.08 3.67 3.20 3.73 3.51 3.30 3.75 3.41 3.69
Plant, Property, & Equipment, net
19 19 19 18 17 16 15 14 13 9.02 8.48
Total Noncurrent Assets
273 270 266 258 253 249 238 234 230 220 216
Goodwill
84 84 84 84 84 84 84 84 84 84 84
Intangible Assets
164 162 159 152 148 144 135 132 128 119 116
Other Noncurrent Operating Assets
24 24 24 22 21 21 19 18 18 16 16
Total Liabilities & Shareholders' Equity
413 405 392 353 337 332 306 296 310 294 290
Total Liabilities
72 71 67 51 43 40 33 34 32 31 30
Total Current Liabilities
22 24 25 18 14 14 11 13 13 14 14
Short-Term Debt
2.47 2.81 1.75 0.89 0.33 0.51 0.35 1.12 0.72 1.00 0.94
Accounts Payable
2.49 2.36 2.50 3.56 2.81 2.19 1.93 1.98 1.91 1.65 2.09
Accrued Expenses
3.91 4.93 6.52 4.03 4.55 5.45 3.58 4.71 5.15 4.03 4.50
Current Deferred Revenue
6.89 7.27 7.38 5.53 2.91 2.51 1.73 0.98 1.64 2.94 2.26
Other Current Liabilities
2.44 3.42 3.45 3.52 3.56 3.75 3.81 3.84 3.86 3.94 3.97
Total Noncurrent Liabilities
51 47 42 34 29 25 21 21 19 17 16
Capital Lease Obligations
23 23 23 21 21 20 19 18 17 16 15
Noncurrent Deferred Revenue
3.02 3.48 1.95 0.28 0.07 0.04 0.00 0.04 0.00 0.37 0.31
Noncurrent Deferred & Payable Income Tax Liabilities
20 17 14 8.74 6.84 4.13 2.21 2.33 1.17 1.23 0.88
Other Noncurrent Operating Liabilities
3.73 3.42 3.56 3.21 1.24 1.16 0.39 0.66 0.60 0.11 0.09
Total Equity & Noncontrolling Interests
341 334 325 301 294 292 274 262 277 263 260
Total Preferred & Common Equity
341 334 325 301 294 292 274 262 277 263 260
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
341 334 325 301 294 292 274 262 277 263 260
Common Stock
336 343 350 360 366 380 393 398 429 437 440
Retained Earnings
5.15 -9.58 -25 -58 -72 -88 -120 -135 -152 -174 -180
Accumulated Other Comprehensive Income / (Loss)
0.01 -0.05 -0.05 -0.02 -0.03 0.05 0.01 -0.00 0.01 -0.00 -0.02

Annual Metrics And Ratios for Avista Public Acquisition Corp. II

This table displays calculated financial ratios and metrics derived from Avista Public Acquisition Corp. II's official financial filings.

Metric 2021 2022 2023 2024 2025
Period end date 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
DEI Shares Outstanding
- - - - 143,955,400.00
DEI Adjusted Shares Outstanding
- - - - 143,955,400.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - -0.45
Growth Metrics
- - - - -
Revenue Growth
0.00% 70.02% -42.17% -22.75% -29.27%
EBITDA Growth
0.00% 52.63% -522.73% 1.74% 8.34%
EBIT Growth
0.00% 22.41% -160.50% -7.35% 7.47%
NOPAT Growth
0.00% 25.17% -160.50% -7.32% 7.43%
Net Income Growth
0.00% 17.41% -126.65% -22.55% -4.43%
EPS Growth
0.00% 21.21% -96.15% -19.61% 6.56%
Operating Cash Flow Growth
0.00% 36.76% 165.43% -1,789.99% 8.09%
Free Cash Flow Firm Growth
0.00% 0.00% 61.66% -161.01% 37.72%
Invested Capital Growth
0.00% 12.23% -10.59% -1.15% -7.09%
Revenue Q/Q Growth
0.00% 0.00% -47.19% 29.31% -11.51%
EBITDA Q/Q Growth
0.00% 0.00% -136.10% 14.03% 0.37%
EBIT Q/Q Growth
0.00% 0.00% -77.25% 6.65% 0.15%
NOPAT Q/Q Growth
0.00% 0.00% -77.26% 6.67% 0.17%
Net Income Q/Q Growth
0.00% 0.00% -70.17% 1.56% -1.75%
EPS Q/Q Growth
0.00% 0.00% -82.14% 1.61% 3.39%
Operating Cash Flow Q/Q Growth
0.00% 0.00% -45.73% 11.69% -5.20%
Free Cash Flow Firm Q/Q Growth
0.00% 0.00% 0.00% 12.69% 1.92%
Invested Capital Q/Q Growth
0.00% 0.00% -0.56% -1.92% -2.28%
Profitability Metrics
- - - - -
Gross Margin
100.00% 100.00% 100.00% 100.00% 98.38%
EBITDA Margin
-52.06% -14.50% -156.19% -198.67% -257.46%
Operating Margin
-102.48% -45.11% -203.19% -282.30% -369.49%
EBIT Margin
-98.83% -45.11% -203.19% -282.36% -369.41%
Profit (Net Income) Margin
-77.82% -37.80% -148.16% -235.05% -347.04%
Tax Burden Percent
78.72% 85.70% 78.65% 86.87% 97.71%
Interest Burden Percent
100.02% 97.80% 92.72% 95.83% 96.14%
Effective Tax Rate
0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)
-9.97% -7.03% -18.28% -20.90% -20.17%
ROIC Less NNEP Spread (ROIC-NNEP)
-23.35% 9.38% -15.02% -1.74% 23.22%
Return on Net Nonoperating Assets (RNNOA)
-1.58% -0.73% 2.85% 0.30% -3.18%
Return on Equity (ROE)
-11.54% -7.76% -15.43% -20.60% -23.36%
Cash Return on Invested Capital (CROIC)
0.00% -18.55% -7.10% -19.74% -12.82%
Operating Return on Assets (OROA)
-11.28% -7.34% -17.43% -21.27% -22.01%
Return on Assets (ROA)
-8.88% -6.16% -12.71% -17.70% -20.68%
Return on Common Equity (ROCE)
-11.54% -7.76% -15.43% -20.60% -23.36%
Return on Equity Simple (ROE_SIMPLE)
-11.54% -6.54% -16.09% -21.57% 0.00%
Net Operating Profit after Tax (NOPAT)
-25 -19 -49 -52 -48
NOPAT Margin
-71.73% -31.58% -142.24% -197.61% -258.64%
Net Nonoperating Expense Percent (NNEP)
13.38% -16.41% -3.26% -19.16% -43.40%
Return On Investment Capital (ROIC_SIMPLE)
- - -14.38% -16.96% -16.97%
Cost of Revenue to Revenue
0.00% 0.00% 0.00% 0.00% 1.62%
SG&A Expenses to Revenue
48.77% 42.15% 97.51% 116.48% 156.51%
R&D to Revenue
112.90% 81.87% 165.45% 208.82% 255.83%
Operating Expenses to Revenue
202.48% 145.11% 303.19% 382.30% 467.87%
Earnings before Interest and Taxes (EBIT)
-34 -27 -69 -75 -69
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-18 -8.57 -53 -52 -48
Valuation Ratios
- - - - -
Price to Book Value (P/BV)
0.00 0.30 2.28 1.49 1.00
Price to Tangible Book Value (P/TBV)
0.00 1.15 9.55 6.53 4.60
Price to Revenue (P/Rev)
0.00 1.75 20.99 16.23 14.27
Price to Earnings (P/E)
0.00 0.00 0.00 0.00 0.00
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
0.00 0.15 2.60 1.57 1.00
Enterprise Value to Revenue (EV/Rev)
0.00 0.73 19.13 14.73 12.31
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.00 278.48 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 0.00 0.00
Leverage & Solvency
- - - - -
Debt to Equity
0.07 0.08 0.07 0.07 0.07
Long-Term Debt to Equity
0.06 0.07 0.07 0.07 0.06
Financial Leverage
0.07 -0.08 -0.19 -0.17 -0.14
Leverage Ratio
1.30 1.26 1.21 1.16 1.13
Compound Leverage Factor
1.30 1.23 1.13 1.12 1.09
Debt to Total Capital
6.32% 7.59% 6.92% 6.48% 6.15%
Short-Term Debt to Total Capital
1.01% 1.09% 0.39% 0.17% 0.37%
Long-Term Debt to Total Capital
5.31% 6.50% 6.53% 6.30% 5.78%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
93.68% 92.41% 93.08% 93.52% 93.84%
Debt to EBITDA
-0.87 -3.27 -0.44 -0.38 -0.36
Net Debt to EBITDA
-0.87 7.03 1.19 0.75 0.76
Long-Term Debt to EBITDA
-0.73 -2.80 -0.41 -0.37 -0.34
Debt to NOPAT
-0.63 -1.50 -0.48 -0.38 -0.36
Net Debt to NOPAT
-0.63 3.23 1.31 0.76 0.76
Long-Term Debt to NOPAT
-0.53 -1.29 -0.45 -0.37 -0.34
Altman Z-Score
0.00 1.03 6.66 5.86 3.44
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - -
Current Ratio
1.10 4.80 4.11 4.52 4.02
Quick Ratio
1.03 4.56 3.93 4.29 3.78
Cash Flow Metrics
- - - - -
Free Cash Flow to Firm (FCFF)
0.00 -49 -19 -49 -31
Operating Cash Flow to CapEx
-139.36% -20.89% 142.76% -2,115.41% -6,452.21%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense
-810.29 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
-1,391.71 0.00 0.00 0.00 0.00
Efficiency Ratios
- - - - -
Asset Turnover
0.11 0.16 0.09 0.08 0.06
Accounts Receivable Turnover
1.64 2.30 2.00 5.79 2.95
Inventory Turnover
0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
5.11 4.41 1.79 1.56 1.50
Accounts Payable Turnover
0.00 0.00 0.00 0.00 0.15
Days Sales Outstanding (DSO)
222.02 158.86 182.34 63.04 123.80
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)
0.00 0.00 0.00 0.00 2,515.25
Cash Conversion Cycle (CCC)
222.02 158.86 182.34 63.04 -2,391.45
Capital & Investment Metrics
- - - - -
Invested Capital
250 281 251 248 231
Invested Capital Turnover
0.14 0.22 0.13 0.11 0.08
Increase / (Decrease) in Invested Capital
0.00 31 -30 -2.88 -18
Enterprise Value (EV)
0.00 43 654 389 230
Market Capitalization
0.00 104 717 428 266
Book Value per Share
$8.15 $4.00 $2.71 $2.38 $1.85
Tangible Book Value per Share
($0.90) $1.06 $0.65 $0.54 $0.40
Total Capital
250 369 338 308 285
Total Debt
16 28 23 20 17
Total Long-Term Debt
13 24 22 19 16
Net Debt
16 -60 -64 -40 -37
Capital Expenditures (CapEx)
4.07 17 1.64 1.88 0.57
Debt-free, Cash-free Net Working Capital (DFCFNWC)
4.50 15 -14 -5.85 -3.89
Debt-free Net Working Capital (DFNWC)
4.50 103 73 54 50
Net Working Capital (NWC)
1.97 99 72 53 49
Net Nonoperating Expense (NNE)
2.12 3.68 2.03 9.88 17
Net Nonoperating Obligations (NNO)
16 -61 -64 -40 -37
Total Depreciation and Amortization (D&A)
16 18 16 22 21
Debt-free, Cash-free Net Working Capital to Revenue
12.96% 24.86% -40.67% -22.18% -20.86%
Debt-free Net Working Capital to Revenue
12.96% 174.26% 213.93% 203.03% 268.57%
Net Working Capital to Revenue
5.66% 167.46% 210.12% 201.02% 262.98%
Earnings Adjustments
- - - - -
Adjusted Basic Earnings per Share
$0.00 ($0.26) ($0.51) ($0.61) ($0.57)
Adjusted Weighted Average Basic Shares Outstanding
0.00 85.32M 99.68M 102.37M 113.64M
Adjusted Diluted Earnings per Share
$0.00 ($0.26) ($0.51) ($0.61) ($0.57)
Adjusted Weighted Average Diluted Shares Outstanding
0.00 85.32M 99.68M 102.37M 113.64M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
0.00 115.58M 117.13M 122.13M 144.78M
Normalized Net Operating Profit after Tax (NOPAT)
-25 -19 -49 -52 -48
Normalized NOPAT Margin
-71.73% -31.58% -142.24% -197.61% -258.64%
Pre Tax Income Margin
-98.85% -44.11% -188.39% -270.59% -355.16%
Debt Service Ratios
- - - - -
EBIT to Interest Expense
-4,906.14 0.00 0.00 0.00 0.00
NOPAT to Interest Expense
-3,560.90 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense
-5,487.57 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense
-4,142.33 0.00 0.00 0.00 0.00
Payout Ratios
- - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00%

Quarterly Metrics And Ratios for Avista Public Acquisition Corp. II

This table displays calculated financial ratios and metrics derived from Avista Public Acquisition Corp. II's official financial filings.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
DEI Shares Outstanding
- - - - - 122,134,941.00 122,335,336.00 122,701,294.00 143,955,400.00 144,782,647.00 144,972,579.00
DEI Adjusted Shares Outstanding
- - - - - 122,134,941.00 122,335,336.00 122,701,294.00 143,955,400.00 144,782,647.00 144,972,579.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - -0.15 -0.13 -0.13 -0.10 -0.05 -0.04
Growth Metrics
- - - - - - - - - - -
Revenue Growth
-86.36% -77.53% 9.62% -23.83% 124.06% 9.29% -48.82% -46.33% -22.47% 247.30% 244.24%
EBITDA Growth
-224.54% -302.61% 31.58% 7.12% 50.26% 21.33% -10.92% 9.69% 2.09% 94.86% 78.09%
EBIT Growth
-334.32% -166.80% 16.12% 2.63% 25.12% 16.45% 0.75% 8.21% 0.67% 58.86% 58.96%
NOPAT Growth
-331.77% -166.80% 16.15% 2.71% 25.12% 16.45% 0.53% 8.22% 0.72% 58.45% 59.08%
Net Income Growth
-306.06% -210.84% 7.45% -4.03% 7.01% 4.01% -16.46% -0.93% -8.50% 57.65% 63.09%
EPS Growth
-255.56% -216.67% 13.33% 0.00% 7.14% 10.53% -15.38% 12.50% 15.38% 64.71% 66.67%
Operating Cash Flow Growth
-27.69% -161.51% -21.55% -6.13% 57.55% 6.81% 57.76% -48.42% -46.54% 69.04% 152.06%
Free Cash Flow Firm Growth
0.00% 51.75% 73.44% 66.80% -155.36% 57.26% 155.74% 130.43% 179.68% 276.90% 48.85%
Invested Capital Growth
-10.59% 0.64% 0.58% 0.22% -1.15% -2.26% -7.19% -6.75% -7.09% -7.49% -6.41%
Revenue Q/Q Growth
-11.96% -21.17% 100.32% -45.21% 158.96% -61.55% -6.19% -42.55% 274.10% 72.24% -7.01%
EBITDA Q/Q Growth
-4.73% -6.82% 41.90% -42.88% 43.91% -68.99% 18.08% -16.34% 39.20% 91.13% -249.12%
EBIT Q/Q Growth
-4.43% -6.35% 27.66% -21.20% 19.68% -18.67% 14.07% -12.08% 13.10% 50.85% 14.27%
NOPAT Q/Q Growth
-4.39% -6.35% 27.70% -21.21% 19.65% -18.67% 13.93% -11.84% 13.09% 50.34% 15.23%
Net Income Q/Q Growth
10.71% -34.92% 28.11% -20.12% 20.19% -39.27% 12.77% -4.09% 14.20% 45.65% 23.98%
EPS Q/Q Growth
12.50% -35.71% 31.58% -23.08% 18.75% -30.77% 11.76% 6.67% 21.43% 45.45% 16.67%
Operating Cash Flow Q/Q Growth
-47.16% -86.73% 28.48% 46.00% 41.14% -309.92% 67.58% -89.72% 41.88% 13.39% 154.52%
Free Cash Flow Firm Q/Q Growth
134.33% -216.97% 25.83% -11.46% 42.75% 9.68% 196.73% -39.16% 49.90% 100.52% -18.61%
Invested Capital Q/Q Growth
-0.56% 1.48% 1.32% -1.98% -1.92% 0.34% -3.79% -1.52% -2.28% -0.08% -2.67%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
100.00% 100.00% 100.00% 100.00% 100.00% 99.93% 93.28% 98.70% 99.86% 99.90% 95.45%
EBITDA Margin
-353.84% -479.51% -139.09% -362.68% -78.55% -345.19% -301.41% -610.32% -99.19% -5.11% -19.18%
Operating Margin
-439.78% -593.34% -214.15% -473.73% -146.98% -453.64% -416.19% -810.18% -188.23% -54.27% -49.47%
EBIT Margin
-439.78% -593.34% -214.26% -473.92% -146.98% -453.61% -415.50% -810.54% -188.29% -53.73% -49.54%
Profit (Net Income) Margin
-291.44% -498.84% -179.03% -392.45% -120.96% -438.13% -407.36% -738.05% -169.28% -53.42% -43.68%
Tax Burden Percent
70.17% 87.87% 87.78% 85.81% 85.84% 99.42% 100.76% 93.44% 97.48% 106.08% 94.32%
Interest Burden Percent
94.45% 95.68% 95.19% 96.51% 95.86% 97.15% 97.31% 97.45% 92.23% 93.72% 93.47%
Effective Tax Rate
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)
-39.56% -34.43% -12.65% -26.79% -10.88% -33.72% -26.97% -48.95% -10.28% -4.59% -5.74%
ROIC Less NNEP Spread (ROIC-NNEP)
-40.84% -29.71% -8.74% -22.21% -7.10% -19.67% -11.55% -39.42% -2.01% 3.24% -1.61%
Return on Net Nonoperating Assets (RNNOA)
7.74% 6.22% 1.58% 4.00% 1.22% 2.44% 1.22% 5.57% 0.28% -0.34% 0.18%
Return on Equity (ROE)
-31.83% -28.21% -11.07% -22.79% -9.67% -31.29% -25.75% -43.38% -10.00% -4.93% -5.56%
Cash Return on Invested Capital (CROIC)
-7.10% -23.66% -22.45% -22.33% -19.74% -17.39% -12.44% -12.80% -12.82% -9.15% -7.98%
Operating Return on Assets (OROA)
-37.73% -32.62% -12.53% -26.75% -11.07% -36.83% -30.23% -53.33% -11.22% -5.18% -6.50%
Return on Assets (ROA)
-25.00% -27.43% -10.47% -22.15% -9.11% -35.58% -29.64% -48.56% -10.09% -5.15% -5.73%
Return on Common Equity (ROCE)
-31.82% -28.21% -11.07% -22.79% -9.67% -31.29% -25.75% -43.38% -10.00% -4.93% -5.56%
Return on Equity Simple (ROE_SIMPLE)
0.00% -21.06% -21.21% -21.60% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
-15 -16 -11 -14 -11 -13 -11 -13 -11 -5.48 -4.65
NOPAT Margin
-307.84% -415.34% -149.90% -331.61% -102.89% -317.54% -291.33% -567.13% -131.76% -37.99% -34.63%
Net Nonoperating Expense Percent (NNEP)
1.27% -4.72% -3.91% -4.58% -3.79% -14.06% -15.41% -9.53% -8.27% -7.82% -4.14%
Return On Investment Capital (ROIC_SIMPLE)
-4.39% - - - -3.61% -4.51% -4.04% -4.30% -3.88% -1.96% -1.68%
Cost of Revenue to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.07% 6.72% 1.30% 0.14% 0.10% 4.55%
SG&A Expenses to Revenue
163.19% 219.34% 104.61% 169.68% 68.12% 190.54% 197.18% 302.68% 81.65% 45.88% 49.59%
R&D to Revenue
306.22% 382.82% 183.02% 319.22% 123.16% 303.37% 278.78% 463.56% 166.06% 66.82% 71.46%
Operating Expenses to Revenue
539.78% 693.34% 314.15% 573.73% 246.98% 553.56% 509.47% 908.89% 288.09% 154.16% 144.93%
Earnings before Interest and Taxes (EBIT)
-21 -23 -16 -20 -16 -19 -16 -18 -16 -7.75 -6.65
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-17 -18 -11 -15 -8.49 -14 -12 -14 -8.31 -0.74 -2.57
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
2.28 2.11 1.50 1.71 1.49 1.07 0.81 0.71 1.00 0.87 1.37
Price to Tangible Book Value (P/TBV)
9.55 9.71 7.04 7.86 6.53 5.36 4.58 3.02 4.60 3.82 5.92
Price to Revenue (P/Rev)
20.99 30.16 20.31 24.49 16.23 10.96 9.24 9.31 14.27 7.85 9.27
Price to Earnings (P/E)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
2.60 2.31 1.57 1.82 1.57 1.08 0.79 0.66 1.00 0.85 1.43
Enterprise Value to Revenue (EV/Rev)
19.13 27.94 18.65 22.59 14.73 10.04 8.26 7.34 12.31 6.74 8.33
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
278.48 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.07 0.07 0.07 0.07 0.07 0.07 0.07 0.06 0.07 0.06 0.06
Long-Term Debt to Equity
0.07 0.07 0.07 0.07 0.07 0.07 0.07 0.06 0.06 0.06 0.06
Financial Leverage
-0.19 -0.21 -0.18 -0.18 -0.17 -0.12 -0.11 -0.14 -0.14 -0.11 -0.11
Leverage Ratio
1.21 1.19 1.18 1.17 1.16 1.15 1.14 1.13 1.13 1.12 1.12
Compound Leverage Factor
1.15 1.14 1.13 1.13 1.12 1.11 1.11 1.10 1.04 1.05 1.05
Debt to Total Capital
6.92% 6.89% 6.69% 6.60% 6.48% 6.50% 6.78% 6.07% 6.15% 5.99% 5.75%
Short-Term Debt to Total Capital
0.39% 0.28% 0.10% 0.16% 0.17% 0.12% 0.40% 0.24% 0.37% 0.36% 0.34%
Long-Term Debt to Total Capital
6.53% 6.62% 6.59% 6.43% 6.30% 6.38% 6.38% 5.83% 5.78% 5.63% 5.41%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
93.08% 93.11% 93.30% 93.40% 93.52% 93.49% 93.22% 93.93% 93.84% 94.01% 94.24%
Debt to EBITDA
-0.44 -0.33 -0.34 -0.34 -0.38 -0.39 -0.38 -0.37 -0.36 -0.49 -0.63
Net Debt to EBITDA
1.19 0.70 0.58 0.64 0.75 0.51 0.45 0.86 0.76 0.94 1.43
Long-Term Debt to EBITDA
-0.41 -0.32 -0.33 -0.33 -0.37 -0.38 -0.36 -0.36 -0.34 -0.46 -0.59
Debt to NOPAT
-0.48 -0.38 -0.38 -0.37 -0.38 -0.38 -0.39 -0.37 -0.36 -0.41 -0.47
Net Debt to NOPAT
1.31 0.80 0.64 0.69 0.76 0.50 0.46 0.86 0.76 0.80 1.07
Long-Term Debt to NOPAT
-0.45 -0.37 -0.37 -0.36 -0.37 -0.38 -0.36 -0.36 -0.34 -0.39 -0.44
Altman Z-Score
7.08 7.26 5.94 7.21 6.45 4.89 3.20 3.05 4.03 3.79 6.54
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.01%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
4.11 4.38 4.76 4.63 4.52 4.70 3.77 5.00 4.02 4.80 4.80
Quick Ratio
3.93 4.17 4.53 4.37 4.29 4.39 3.51 4.71 3.78 4.55 4.53
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
15 -17 -13 -14 -8.23 -7.44 7.19 4.38 6.56 13 11
Operating Cash Flow to CapEx
-8,524.30% -1,839.31% -1,622.10% -4,327.63% -8,417.39% -7,594.26% -3,118.79% -5,364.29% -63,044.44% -2,942.52% 2,435.45%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.09 0.06 0.06 0.06 0.08 0.08 0.07 0.07 0.06 0.10 0.13
Accounts Receivable Turnover
2.00 7.18 2.80 4.24 5.79 5.08 4.81 6.40 2.95 3.03 5.90
Inventory Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
1.79 1.13 1.19 1.17 1.56 1.64 1.47 1.42 1.50 2.44 3.41
Accounts Payable Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.11 0.14 0.15 0.18 0.33
Days Sales Outstanding (DSO)
182.34 50.85 130.16 86.13 63.04 71.81 75.94 57.02 123.80 120.56 61.85
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)
0.00 0.00 0.00 0.00 0.00 333,914.17 3,333.76 2,568.17 2,515.25 2,077.02 1,118.95
Cash Conversion Cycle (CCC)
182.34 50.85 130.16 86.13 63.04 -333,842.36 -3,257.82 -2,511.16 -2,391.45 -1,956.47 -1,057.09
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
251 255 258 253 248 249 240 236 231 230 224
Invested Capital Turnover
0.13 0.08 0.08 0.08 0.11 0.11 0.09 0.09 0.08 0.12 0.17
Increase / (Decrease) in Invested Capital
-30 1.61 1.49 0.55 -2.88 -5.76 -19 -17 -18 -19 -15
Enterprise Value (EV)
654 588 405 461 389 269 190 155 230 195 321
Market Capitalization
717 635 441 500 428 293 213 196 266 227 357
Book Value per Share
$2.71 $2.57 $2.50 $2.47 $2.38 $2.24 $2.14 $2.26 $1.85 $1.81 $1.80
Tangible Book Value per Share
$0.65 $0.56 $0.53 $0.54 $0.54 $0.45 $0.38 $0.53 $0.40 $0.41 $0.42
Total Capital
338 324 315 312 308 293 281 295 285 279 276
Total Debt
23 22 21 21 20 19 19 18 17 17 16
Total Long-Term Debt
22 21 21 20 19 19 18 17 16 16 15
Net Debt
-64 -47 -36 -39 -40 -25 -23 -42 -37 -32 -36
Capital Expenditures (CapEx)
0.11 0.93 0.75 0.15 0.05 0.21 0.17 0.18 0.01 0.17 0.11
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-14 -8.92 -3.75 -6.66 -5.85 -1.07 -5.51 -5.71 -3.89 3.49 1.20
Debt-free Net Working Capital (DFNWC)
73 60 53 53 54 43 36 54 50 53 53
Net Working Capital (NWC)
72 59 53 52 53 42 35 53 49 52 52
Net Nonoperating Expense (NNE)
-0.79 3.17 2.22 2.54 1.95 5.01 4.52 3.83 3.14 2.23 1.21
Net Nonoperating Obligations (NNO)
-64 -47 -36 -39 -40 -25 -23 -42 -37 -32 -36
Total Depreciation and Amortization (D&A)
4.14 4.33 5.72 4.64 7.39 4.50 4.45 4.48 7.46 7.02 4.07
Debt-free, Cash-free Net Working Capital to Revenue
-40.67% -42.38% -17.27% -32.65% -22.18% -4.00% -23.94% -27.06% -20.86% 12.06% 3.12%
Debt-free Net Working Capital to Revenue
213.93% 285.51% 246.27% 258.30% 203.03% 159.00% 156.79% 255.01% 268.57% 181.63% 138.32%
Net Working Capital to Revenue
210.12% 281.27% 244.76% 255.80% 201.02% 157.68% 151.91% 251.60% 262.98% 178.16% 135.88%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
($0.14) ($0.19) ($0.13) ($0.16) ($0.13) ($0.17) ($0.15) ($0.14) ($0.11) ($0.06) ($0.05)
Adjusted Weighted Average Basic Shares Outstanding
99.68M 100.76M 101.46M 102.39M 102.37M 105.62M 106.15M 114.73M 113.64M 128.25M 128.80M
Adjusted Diluted Earnings per Share
($0.14) ($0.19) ($0.13) ($0.16) ($0.13) ($0.17) ($0.15) ($0.14) ($0.11) ($0.06) ($0.05)
Adjusted Weighted Average Diluted Shares Outstanding
99.68M 100.76M 101.46M 102.39M 102.37M 105.62M 106.15M 114.73M 113.64M 128.25M 128.80M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
117.13M 117.62M 118.16M 121.01M 122.13M 122.34M 122.70M 143.96M 144.78M 144.97M 145.39M
Normalized Net Operating Profit after Tax (NOPAT)
-15 -16 -11 -14 -11 -13 -11 -13 -11 -5.48 -4.65
Normalized NOPAT Margin
-307.84% -415.34% -149.90% -331.61% -102.89% -317.54% -291.33% -567.13% -131.76% -37.99% -34.63%
Pre Tax Income Margin
-415.35% -567.69% -203.95% -457.36% -140.90% -440.68% -404.31% -789.91% -173.66% -50.36% -46.31%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Financials Breakdown Chart

Key Financial Trends

OmniAb’s Q2 2026 results show meaningful improvement in revenue, operating losses and operating cash flow, although the company remains unprofitable and continues to rely heavily on its cash and investment portfolio.

  • Revenue growth accelerated: Q2 2026 revenue was $13.4 million, up from $3.9 million in the restated Q2 2025 period. Revenue also increased substantially from $2.2 million in Q3 2025 and $8.4 million in Q4 2025, although it declined 7% sequentially from $14.4 million in Q1 2026.
  • Gross margins remained very high: Gross profit was $12.8 million, representing approximately a 95.5% gross margin. The company’s cost of revenue was only $610,000 in the quarter.
  • Net losses narrowed significantly: Q2 2026 net loss was $5.9 million, compared with a $7.7 million loss in Q1 2026 and a $15.9 million loss in Q2 2025. Basic and diluted loss per share improved to $0.05 from $0.06 in Q1 and $0.15 in the year-ago quarter.
  • Operating losses improved: Operating loss narrowed to $6.6 million from $7.8 million in Q1 2026 and $16.2 million in Q2 2025. Selling, general and administrative expense declined modestly year over year, while research and development expense also fell slightly.
  • Operating cash flow turned positive: OmniAb generated $2.7 million of cash from operations in Q2 2026, compared with operating cash outflows of $4.9 million in Q1 2026 and $5.1 million in Q2 2025. This was a notable improvement, although it was helped by $1.3 million from changes in operating assets and liabilities and substantial noncash adjustments.
  • Liquidity remains strong relative to current obligations: Cash and short-term investments totaled approximately $52.0 million at June 30, 2026. Current assets of $66.0 million compared with current liabilities of $13.8 million, producing a current ratio of roughly 4.8.
  • Cash declined during the quarter: Cash and equivalents fell to $24.3 million from $29.0 million in Q1, while total cash and short-term investments declined modestly from $49.1 million to $52.0 million when considering the investment balance. The company’s $4.7 million net decrease in cash reflected negative investing cash flow of $7.6 million, partly offset by positive operating cash flow.
  • Investment activity is a major source of cash management: OmniAb purchased $23.6 million of investments and sold or received maturities of $16.1 million in Q2. Similar investment purchases and maturities have occurred in prior quarters, so changes in investing cash flow may reflect portfolio management rather than core business performance.
  • The company remains structurally unprofitable: OmniAb has reported net losses in every provided quarter since Q1 2023 except Q4 2022. Retained earnings were negative $179.7 million at June 30, 2026, highlighting the accumulated impact of ongoing losses.
  • Share dilution is a concern: Weighted average basic shares outstanding increased to 128.8 million in Q2 2026 from 106.1 million in the restated Q2 2025 period. The higher share count can reduce per-share returns for existing investors and may indicate continued reliance on equity-based compensation or equity issuance.
  • Asset concentration creates impairment risk: Goodwill and intangible assets totaled approximately $200.0 million, or about 69% of total assets. If expected future cash flows weaken, impairment charges could materially reduce reported equity and increase losses.
  • Cash generation has not yet proven durable: Although Q2 operating cash flow was positive, OmniAb generated operating cash outflows in Q3 and Q4 2025 and Q1 2026. Investors should determine whether the latest improvement reflects sustainable revenue growth or temporary working-capital movements.

Overall, the latest quarter points to improving commercial momentum and better cost control, but OmniAb still needs to convert revenue growth into consistent operating profitability and recurring cash generation. The company’s substantial liquidity provides time to execute its strategy, while persistent losses, dilution and the large goodwill and intangible-asset balance remain important risks.

10/05/26 02:50 PM ETAI Generated. May Contain Errors.

Avista Public Acquisition Corp. II Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Avista Public Acquisition Corp. II's financial year ends in December. Their financial year 2025 ended on December 31, 2025.

Avista Public Acquisition Corp. II's net income appears to be on a downward trend, with a most recent value of -$64.78 million in 2025, falling from -$27.04 million in 2021. The previous period was -$62.03 million in 2024.

Avista Public Acquisition Corp. II's total operating income in 2025 was -$68.97 million, based on the following breakdown:
  • Total Gross Profit: $18.36 million
  • Total Operating Expenses: $87.33 million

Over the last 4 years, Avista Public Acquisition Corp. II's total revenue changed from $34.75 million in 2021 to $18.67 million in 2025, a change of -46.3%.

In the past 13 quarters, Avista Public Acquisition Corp. II's cash and equivalents has ranged from $10.89 million in Q1 2025 to $29.05 million in Q1 2026, and is currently $24.34 million as of their latest financial filing in Q2 2026.

Avista Public Acquisition Corp. II had total debt of $17.50 million at the end of 2025, a 12.1% decrease from 2024, and a 10.7% increase since 2021.

Over the last 4 years, Avista Public Acquisition Corp. II's book value per share changed from 8.15 in 2021 to 1.85 in 2025, a change of -77.2%.



Financial statements for NASDAQ:AHPAW last updated on 8/7/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners